PC945 Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and tolerability of PC945 for the prevention of fungal
aspergillus infections in the lung in patients who have received a lung transplant.